Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum.
about
Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview SurveyOutcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasoundMultibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgiaThe effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation.A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.No Association of Fibromyalgia and Seronegative Rheumatoid Arthritis-The Need for Uniform Application of Fibromyalgia Criteria in Research Studies: Comment on the Article by Doss et al.Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia.High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis.Standards of Comparison and Discordance in Rheumatoid Arthritis Global Assessments Between Patients and Clinicians.
P2860
Q33883662-4076B6B7-69B5-43A9-A1D0-5A4490D4DCD8Q35778493-32B8C7FA-A8F5-4BB6-8B56-34E0E8F494A5Q35954700-8D65F4B1-6AC7-4548-B42D-B01E9DC4C41CQ36141747-A746D488-DEAA-43AC-993C-22983F4E3E30Q36696967-7FBEEF15-01E6-43C2-A552-19E66B51377EQ36885296-F15F1C08-5F14-4667-8CAF-BA38CECBC445Q41670046-7F3AE2F3-FF6B-47F2-90D3-80380BD05796Q42368093-B20DED77-6FB7-4739-8943-B521B9048D13Q44194868-270DF7BF-E768-4464-879B-B06664626050Q47775210-0213B008-8467-4B5D-B529-A078C55505F6Q48346445-E801445B-2522-43A6-9294-3232A8EBECB4Q50141423-B15CA0AB-11F8-46DC-A575-ED2E5155DCAE
P2860
Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Polysymptomatic distress in pa ...... ate response and its spectrum.
@en
Polysymptomatic distress in pa ...... ate response and its spectrum.
@nl
type
label
Polysymptomatic distress in pa ...... ate response and its spectrum.
@en
Polysymptomatic distress in pa ...... ate response and its spectrum.
@nl
prefLabel
Polysymptomatic distress in pa ...... ate response and its spectrum.
@en
Polysymptomatic distress in pa ...... ate response and its spectrum.
@nl
P2093
P2860
P356
P1476
Polysymptomatic distress in pa ...... ate response and its spectrum.
@en
P2093
Brian T Walitt
Johannes J Rasker
Kaleb Michaud
Robert S Katz
Ruth E Busch
Shadi H Shahouri
Shirley Wang
Timothy S Shaver
P2860
P304
P356
10.1002/ACR.22300
P577
2014-10-01T00:00:00Z